About us
- >
- About us >
- Information >
- Announcement
Announcement
-
2019-11-08The IND application of ENERGI-F703 for treating venous leg ulcers (VLU) has been approved by the US FDA
-
2019-10-23The Phase II trial of ENERGI-F703 Diabetic Foot Ulcer Gel meets the primary endpoint. Energenesis is planning phase III clinical trials
-
2019-10-17The Korea patent “Composition for promoting hair growth” is granted.
-
2019-10-15BioJapan 2019 attendance
-
2019-08-30The US patent “Method for enhancing wound healing” is granted.
-
2019-08-19The phase II trial of ENERGI-F701 solution for female hair loss treatment has achieved the goal of target patient enrollment.
-
2019-08-12The European patent “Composition for promoting hair growth” is granted.
-
2019-08-01Energenesis-Biomedical announced the implementation for “2019 Grant in collaboration with EB” since Aug 1, 2019.
-
2019-07-30Energenesis Biomedical awards scholarships to EB patients.
-
2019-06-20Energenesis-Biomedical announced collaborators from 15 universities/institutes in funds for “2019 Grant in collaboration with EB”.